Monopar Therapeutics Q1 2026 Earnings Narrower Loss Surprises Market PYPD Q1 2026 Earnings Narrower Loss than Expected Drives Positive Sentiment OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue MYPS Q1 2026 Earnings EPS Misses Estimates but Stock Rises Over 6 OKTA Q1 2026 Earnings EPS Beat Drives Positive Market Reaction WMK Q3 2023 Earnings Reported EPS of 086 with Modest Stock Response